Search Tag: #ESCcongress

Cardiology Management

#ESCCongress: BRACE CORONA Trial and Safety of Heart Drugs

2020 01 Sep

Heart patients hospitalised with COVID-19 can safely continue taking angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs), according to the BRACE CORONA trial presented in a Hot Line session today at ESC Congress 2020. ACE inhibitors and ARBs are commonly taken by heart patients to reduce blood pressure and to... Read more

Cardiology Management

#ESCCongress: Findings from DAPA-CKD Trial

2020 30 Aug

The main results of the DAPA-CK trial were presented today at ESC Congress 2020. Findings showed that dapagliflozin reduces the risk of kidney failure, death from cardiovascular causes or heart failure hospitalisation and all-cause mortality in chronic kidney disease patients with or without type 2 diabetes. The goal of the DAPA-CKD trial was to... Read more

Cardiology Management

#ESCCongress: Results from the EXPLORER-HCM Trial

2020 30 Aug

New findings presented at the ESC Congress show that mavacemten improves heart function and symptoms in patients with obstructive hypertrophic cardiomyopathy (HCM).    To date, the medical treatments for obstructive HCM focus on symptom relief but do not address the underlying causes. These treatments also offer modest efficacy with significant... Read more

Cardiology Management

#ESCCongress: EMPEROR-Reduced Trial Meets Primary Endpoint

2020 29 Aug

In a Hot Line session today at ESC Congress 2020, findings from the EMPEROR-Reduced trial showed that empagiflozin reduces the risk of cardiovascular death or hospitalisation for heart failure in patients with heart failure and a reduced ejection fraction. The findings are published in the New England Journal of Medicine.  The clinical trial evaluated... Read more

Cardiology Management

#ESCCongress: Vaccines Against Respiratory Infections Reduce Heart Failure Deaths

2020 29 Aug

According to new findings presented at the ESC Congress 2020, influenza and pneumonia vaccinations are associated with fewer hospital deaths in heart failure patients.  Approximately 26 million people are affected with heart failure worldwide. It is estimated that one out of five individuals will develop heart failure in their lifetime. Heart failure... Read more

Cardiology Management

#ESCCongress 2020 Moves 100% Online

2020 07 May

ESC Congress – the world’s largest cardiovascular event – moves 100% online for the first time in its 70-year history, to create ESC Congress 2020 – Challenging Times, Infinite Possibilities. Mark your calendars now and join the Congress online from Saturday, 29 August to Tuesday, 1 September. The decision by the European Society of Cardiology... Read more

Cardiology Management

Top Cardiology Stories of 2019

2019 27 Dec

As we move into 2020, here's a quick recap of our most clicked stories in Cardiology in 2019:  ORION-10 Trial: Inclisiran Effective at Reducing LDL Findings from the ORION-10 trial presented at the AHA Scientific Session in 2019 showed that twice-yearly injections of inclisiran were effective at reducing LDL cholesterol. ENCOURAGE... Read more

Executive Health Management

New Management Pathways in Cardiovascular Risk Factors

2019 02 Oct

Summary: A presentation of a case study in light of the updated ESC guidelines on lipid control and new guidelines on diabetes and cardiovascular disease. Several new guidelines were released at the European Society of Cardiology (ESC) Congress in Paris, France. These included updated guidelines on lipid control and new guidelines... Read more

Cardiology Management

#ESCCongress: Artificial Intelligence for Heart Attack Prediction

2019 04 Sep

New findings presented at the ESC Congress in Paris demonstrated technology that uses artificial intelligence (AI) to identify people at high risk of a fatal heart attack at least five years before it strikes. These findings are published in the European Heart Journal. The technology has been developed by researchers at the University of Oxford.... Read more

Cardiology Management

#ESCCongress: New Management Pathways in Cardiovascular Risk Factors

2019 03 Sep

At the ESC Congress this year, several new guidelines have been released including updated guidelines on lipid control and new guidelines on diabetes and cardiovascular disease.  As per the updated guidelines on lipid control ,  the following are some key recommendations:  Low-density lipoprotein (LDL) cholesterol levels should be lowered... Read more